Odyssey Health (ODYY) Other Non-Current Liabilities (2019 - 2026)
Odyssey Health's (ODYY) quarterly Other Non-Current Liabilities came in at $2.4 million in Q2 2026, down 38.25% quarter-over-quarter from $3.9 million in Q1 2026.
Odyssey Health (ODYY) Other Non-Current Liabilities (2019 - 2026) Analysis & Trends
Odyssey Health's Other Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $2.4 million for Q2 2026.
- On a quarterly basis, Other Non-Current Liabilities changed N/A year-over-year to $2.4 million in Q2 2026; TTM through Apr 2026 was $2.4 million, a N/A change from a year earlier, with the FY2019 full-year figure at $144000.0, changed N/A from the prior year.
- Other Non-Current Liabilities slipped to $2.4 million in Q2 2026 per ODYY's latest filing, from $3.9 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $3.9 million in Q1 2026 and bottomed at $225155.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Odyssey Health | 1.08 Mn | 782,508.17 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 2.43 Mn |
| Jan 31, 2026 | 3.94 Mn |
| Oct 31, 2025 | 225,155.00 |
| Apr 30, 2020 | 144,000.00 |
| Jan 31, 2020 | 144,000.00 |
| Oct 31, 2019 | 144,000.00 |
| Jul 31, 2019 | 144,000.00 |